Skip to content

DR. MARC DIRIX

Active Private limited companyfounded 2008active for 17 yearsTenierslaan 16, 3500 HasseltKBO/BCE: BE 0808.354.943

Lifetime

17 annual accounts with figures on one time axis
peak of €164,515 in 2025
€164,515▲ 10.8%
peak of €90,671 in 2025
€90,671▲ 15.5%
peak of €389,333 in 2025
€389,333▲ 30.4%
€181,098▼ 19.8%
Board2 names since 2008
2 directors and 1 other
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Equity from €298,661 to €389,333Debts from €225,855 to €181,098Cash from €84,325 to €140,043

Key points

from the 2025 annual accounts

Equity

€389,333 ▲ 30.4%

DR. MARC DIRIX has made a profit in every financial year since 2009.

Liquidity

3.48 was 1.98 in 2024

Short-term debts fell from €88,219 to €67,597.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Two of the last ten came late. The 2016 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as DR. MARC DIRIX has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for DR. MARC DIRIX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 08-03-2024
Director, since 08-03-2024
  • 100 sharesdeed of 12-03-2024
Board & ownership

Recent changes

Left the Peppol Directory
(director) and (director) change roles “Aangaan en toestaan leningen en kredietopeningen; Management- en holdingactiviteiten; Beheer roerend en…” (deed in Dutch) · holds 100 shares · General meeting of 08-03-2024 · Gazette deed
Registered office moved within Hasselt The registered office moved from Heilig-Hartplein 15/14, 3500 Hasselt to Tenierslaan 16, 3500 Hasselt · General meeting of 07-04-2014 · Gazette deed
appointed as manager General meeting of 17-02-2011 · Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company
DR. MARC DIRIX Hasselt €570,431 €164,515 68.3% -
Dr. An Timmermans Hasselt €566,750 €161,752 81.4% -
Dr. Elke Stevens Pelt €584,608 €172,992 81.9% -
Dr. JOOSEN Henk Sint-Truiden €544,099 €162,140 84.5% -
DOKTER KRISTEL COCHET Lanaken €588,535 €146,117 77.6% -
MEDICALMAX Koekelberg €604,025 €166,194 73.9% -
DOCTEUR SOUGNE CHRISTEL Theux €552,548 €156,256 92.9% -

These companies have the same main activity as DR. MARC DIRIX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €544,000 and €604,000, founded between 2008 and 2010.

Official details

Source: KBO
Status
Active since 11-12-2008Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.229.220.7423500 Hasselt, since 26-11-2008
Financial year end
31 December
Peppol
Left the register on 13-11-2026
Company details

Annual accounts 2025

≈ €310,000estimated
€570,431▲ 8.8%
Filing
Filed on 24-07-2026, 7 days before the end of the filing period
Financials

Insights on DR. MARC DIRIX

DR. MARC DIRIX files the micro format. That format states no turnover. The gross margin rose from €89,405 in 2009 to €164,515 in 2025.

The balance sheet grew most from 2019 to 2021 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. MARC DIRIX

What is the company number of DR. MARC DIRIX?
The company number of DR. MARC DIRIX is 0808.354.943. The VAT number is the same number with BE in front: BE 0808.354.943.
Where is DR. MARC DIRIX based?
The registered office is at Tenierslaan 16, 3500 Hasselt.Company details
What does DR. MARC DIRIX do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. MARC DIRIX?
DR. MARC DIRIX is a private limited company (BV).
When was DR. MARC DIRIX founded?
DR. MARC DIRIX was founded on 11-12-2008.
Is DR. MARC DIRIX still active?
Yes, DR. MARC DIRIX is an active enterprise in the KBO register.
What is the turnover of DR. MARC DIRIX?
The turnover in financial year 2025 is about €310,000. This figure is estimated from the gross margin of €164,515 and 40 comparable companies (NACE 86220). It probably lies between €260,000 and €410,000.Financials
Is DR. MARC DIRIX profitable?
In financial year 2025, DR. MARC DIRIX made a profit of €90,671.
Where can I find the annual accounts of DR. MARC DIRIX?
DR. MARC DIRIX filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. MARC DIRIX due?
DR. MARC DIRIX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.